How Big Data Helps Identify Cancerous Mutations
A scientist working in AI for cancer research published a study detailing research that uses big data to find cancerous mutations in cells.
Read MorePosted by Andy Lundin | Jul 8, 2022 | Cancer |
A scientist working in AI for cancer research published a study detailing research that uses big data to find cancerous mutations in cells.
Read MorePosted by Andy Lundin | Jul 7, 2022 | Company News, Lung Cancer |
Medial EarlySign signed a new partnership with Roche to create innovative, evidence-based solutions for early detection of lung cancer.
Read MorePosted by Andy Lundin | Jun 21, 2022 | Cancer, Company News |
Global diagnostic laboratory company Artemis DNA closed its Houston, Texas facility to optimize the company’s strategy in California.
Read MorePosted by Andy Lundin | Jun 15, 2022 | Cancer |
The USA-Japan Workshop on Biomarkers for Cancer Early Detection presented research on the early detection and prevention of cancer.
Read MorePosted by Chris Wolski | Jun 10, 2022 | Lung Cancer |
FoundationOne CDx has been approved by the FDA to be used as a companion diagnostic for the two indications of Rozlytrek (entrectinib).
Read More